بر اساس عنوان

1
Neurological artform
2
Neurological aspects of hair growth
3
Neurological aspects of multiple myeloma and related disorders
4
Neurological aspects of spinal-cord repair: promises and challenges
5
Neurological aspects of the Angelman syndrome
6
Neurological bases for balance–anxiety links
7
Neurological bases of behavioral development in infancy
8
Neurological basis of skill learning
9
Neurological cases for experts only!
10
Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction
11
Neurological Complication of Infective Endocarditis Misdiagnosing with Multiple Sclerosis: A Case Report
12
Neurological complications and Japanese encephalitis vaccination
13
Neurological Complications Following Percutaneous Coronary Interventions (A Report from the 2000–2001 New York State Angioplasty Registry)
14
Neurological complications in heparin-induced thrombocytopenia
15
Neurological complications in renal failure: a review
16
Neurological complications in β-thalassemia
17
Neurological Complications of Corona Virus: A Mini-Review
18
Neurological complications of HIV infection
19
Neurological complications of HIV infection
20
Neurological Compromise Associated With COVID-19 Is Broader Than Anticipated Comment on “COVID-19 Pandemic and Neurological Disease: A Critical Review of the Existing Literature”
21
Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in 3 Cases of Tyrosinemia
22
Neurological deficit as the first manifestation of vesical transitional cell carcinoma
23
neurological deficit following combined spinal-Epidural Anesthesia for knee arthroplasty
24
Neurological Disorders and Oxidative Toxic Stress: A Role of Metal Nanoparticles
25
Neurological disorders and the structure of human consciousness
26
Neurological disorders caused by inherited ion-channel mutations
27
Neurological Disorders due to Recurrent Hypoglycemia
28
Neurological disturbances due to filgrastim
29
Neurological Dysfunction in Elderly Patients Undergoing Coronary Artery Bypass Operation
30
Neurological effects of high-dose idebenone in patients with Friedreichʹs ataxia: a randomised, placebo-controlled trial
31
Neurological efficacy of stavudine, zidovudine, and lamivudine
32
Neurological efficacy of stavudine, zidovudine, and lamivudine
33
Neurological evaluation and intelligence testing in the child with operated congenital heart disease
34
Neurological Examination and Hearing Assessment of Premature Infants with Gestational Age of Less Than 32 Weeks at Follow-up
35
Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease
36
Neurological finding of Mitochondrial Syndromes (MERRF and MELAS)
37
Neurological findings and outcome in adult cerebral malaria
38
Neurological Functions of CEO Investment based on Varimax Analysis and Rotated Matrix in Q Typology
39
Neurological gait disorders in elderly people: clinical approach and classification
40
NEUROLOGICAL IMPROVEMENT AFTER CERVICAL TRACTION IN PATIENTS WITH CERVICAL SPINE INJURY
41
Neurological infection
42
Neurological infection in The Lancet Neurology
43
Neurological infections: clinical advances and emerging threats
44
Neurological infections: clinical advances, global threats
45
Neurological Involvement of Patients with COVID-19: Proposed Neuroinvasive Mechanisms and Management
46
Neurological manifestation of coeliac disease with particular emphasis on gluten ataxia and immunological injury: a review article
47
Neurological Manifestation of COVID-19: A Literature Review
48
Neurological Manifestations and Risk Factors of HTLV-1 Infection in the Middle East Region and Iran: A Comprehensive Review of 137 Articles of the Last 23 Years
49
Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study
50
Neurological Manifestations as Presenting Feature of Osteopetrosis in Children; A Review of 11 Cases
51
Neurological Manifestations in Critically Ill COVID-19 Patients
52
Neurological manifestations in patients with antiphospholipid syndrome.
53
NEUROLOGICAL MANIFESTATIONS OF ALLGROVE SYNDROME
54
Neurological Manifestations of an Old Disease: A Case Report
55
Neurological manifestations of Behçet’s disease
56
Neurological Manifestations of Celiac Disease
57
Neurological manifestations of dengue infection Original Research Article
58
Neurological manifestations of Ehlers-Danlos syndrome(s): A review.
59
Neurological manifestations of Hansenʹs disease and their management
60
Neurological Manifestations of Hospitalized COVID-19-Infected Patients: A Single-Center Cohort Study
61
Neurological manifestations of knockout mice with β-galactosidase deficiency
62
Neurological Manifestations of Patients Hospitalized with Coronavirus Disease 2019 in Babol, Iran
63
Neurological Manifestations of Renal Diseases in Children in Qazvin/ Iran
64
NEUROLOGICAL MANIFESTATIONS OF WILSONʹS DISEASE
65
Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review
66
Neurological Measurement of Human Trust in Automation Using Electroencephalogram
67
Neurological mechanisms of green tea polyphenols in Alzheimerʹs and Parkinsonʹs diseases
68
Neurological melioidosis
69
Neurological Monitoring and Off-Pump Surgery in a Very High-Risk Stroke Patient
70
Neurological outcome and S100 after coronary artery bypass grafting and abdominal aortic surgery
71
Neurological outcome following delayed fixation of unstable thoracolumbar spinal injuries with short segment posterior fixation
72
Neurological outcome of normothermic versus hypothermic cardiopulmonary bypass in simple congenital heart diseases
73
Neurological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass
74
Neurological presentation of Griscelli syndrome: Obstructive hydrocephalus without haematological abnormalities or organomegaly
75
Neurological presentation of three patients with 22q11 deletion (CATCH 22 syndrome)
76
Neurological presentations of nutritional vitamin B12 deficiency in 42 breastfed infants in Southeast Turkey
77
Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis
78
Neurological recovery in 80 cases of rapid stereotactic evacuation and local fibrinolysis in spontaneous hematomas of putamen and thalamus
79
Neurological Rehabilitation of Stroke Patients by Means of a Robotically Assisted Brain Controlled Interface
80
Neurological sequelae following a high voltage electrical burn
81
Neurological sequelae in children born after in-vitro fertilisation: a population-based study
82
Neurological sequelae in in-vitro fertilisation babies
83
Neurological sequelae in in-vitro fertilisation babies
84
Neurological sequelae in in-vitro fertilisation babies
85
Neurological sequelae in in-vitro fertilisation babies
86
Neurological sequelae of cerebral malaria
87
Neurological sequelae of cerebral malaria
88
Neurological Sequels and Their Causes in Patients Hospitalized in the Toxicology Intensive Care Unit of Bahraloo Hospital, Tehran, Iran
89
Neurological soft signs and response to risperidone in chronic schizophrenia
90
Neurological soft signs in bipolar I disorder patients
91
Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance, and violence?
92
Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia
93
Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder
94
Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder?
95
Neurological Study of Radial Nerve Conduction During Endoscopic Radial Artery Harvesting:An Intra‐Operative Evaluation
96
Neurological Symptom in a Case of Adrenal Insufficiency
97
Neurological Symptoms as the First Presentation of Transitional Cell Carcinoma of Renal Pelvis
98
Neurological Wilson Disease in children: a three years experience from Multan
99
Neurologists are not immune
100
Neurologists determine the effect of migraine on quality of life
101
Neurologists give better stroke care
102
Neurologists say Florida woman is very unlikely to recover
103
Neurology 2.0
104
Neurology elective at The Royal London Hospital
105
Neurology in sub-Saharan Africa—WHO cares?
106
Neurology of paediatric infectious diseases and immunodeficiency
107
Neurology of Touretteʹs syndrome (TS) TS as a developmental dopamine disorder: a hypothesis
108
Neurology of widely embedded free will
109
Neurology on the global health agenda
110
Neurology residency training in Europe: an Italian perspective
111
Neurology starters: simple to sublime
112
Neurology training around the world
113
Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis
114
Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma
115
Neurolymphomatosis of brachial plexus: A rare clinical presentation and the role of 18F-FDG PET/CT
116
Neuromagnetic activity in alpha and beta bands reflect learning-induced increases in coordinative stability
117
Neuromagnetic alpha suppression during an auditory Sternberg task: Evidence for a serial, self-terminating search of short-term memory
118
Neuromagnetic correlates of intra- and extra-dimensional set-shifting
119
Neuromagnetic effects on Anomalous Cognitive Experiences: A Critical Appraisal of the Evidence for Induced Sensed-presence and Haunt-type Experiences
120
Neuromagnetic imaging of cortical oscillations accompanying tactile stimulation
121
Neuromagnetic responses to vowels vs. tones reveal hemispheric lateralization
122
Neuromagnetic source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of data in the same patients
123
Neuromarketing: beyond branding
124
Neuromarketing: Where marketing and neuroscience meet
125
Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo
126
Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway
127
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids
128
Neurometabolic Diagnosis in Children who referred as Neurodevelopmental Delay (A Practical Criteria, in Iranian Pediatric Patients)
129
Neurometabolic Registry Site in Iran
130
Neuromodelling
131
Neuro-models for discharge air temperature system
132
Neuromodulation of parietal and motor activity affects motor planning and execution
133
Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia
134
Neuromodulation: acetylcholine and memory consolidation
135
Neuromodulation: An Overview
136
Neuromodulations of the Intractable Neurologic Symptoms
137
Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease
138
Neuromodulatory role of Bacopa monnieri on oxidative stress induced by postnatal exposure to decabromodiphenyl ether (PBDE -209) in neonate and young female mice
139
Neuromodulatory unpaired median neurons in the New Zealand tree weta, Hemideina femorata
140
Neuromolecularware and its application to pattern recognition
141
Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation
142
Neuromonitoring for awareness during surgery
143
Neuromonitoring of the external branch of the superior laryngeal nerve during thyroid surgery
144
Neuro-monte carlo solution of electrostatic problems
145
Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight
146
Neuromorphic implementation of orientation hypercolumns
147
Neuromorphic Synapses for Artificial Dendrites
148
Neuromotor control in stuttering: Speech, orofacial nonspeech, and finger movements
149
Neuromotor Issues in Human Performance: Introduction
150
Neuromotor Issues in the Learning and Control of Golf Skill
151
Neuro-mucormycosis: Lessons from COVID-19-associated cases
152
Neuromuscular Adjustments of the Quadriceps Muscle After Eccentric Resistance and Concentric Resistance Training
153
Neuromuscular and balance responses to flywheel inertial versus weight training in older persons
154
Neuromuscular and Blood Lactate Response After a Motocross Training Session in Amateur Riders
155
Neuromuscular and Metabolic Responses to Three Different Resistance Exercise Methods
156
Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives
157
Neuromuscular and spatial constraints on bimanual hand-held pendulum oscillations: Dissociation or combination?
158
Neuromuscular Blockade After Ingestion of Tree Tobacco (Nicotiana glauca), ,
159
Neuromuscular blockade as part of an anaesthetic protocol for cataract surgery in an alpaca
160
Neuromuscular Blockade, Bariatric Surgeon Satisfaction, and Quality of Patient Recovery
161
Neuromuscular Blocking Agent Use in Acute Respiratory Distress Syndrome: Which Variable is Important?
162
NEUROMUSCULAR BLOCKING AGENTS IN THE INTENSIVE CARE UNITS
163
Neuromuscular changes in a rat model of colitis
164
Neuromuscular Characteristics of Endurance- and Power-Trained Athletes
165
Neuromuscular consequences of prolonged hunger strike: an electrophysiological study
166
Neuromuscular Control and Coordination During Cycling
167
Neuromuscular control model of the arm including feedback and feedforward components
168
Neuromuscular disease laboratory
169
Neuromuscular diseases: therapeutic advances
170
Neuromuscular disorder in response to anterior cruciate ligament creep
171
Neuromuscular disorders in critical illness
172
Neuromuscular disorders: molecular and therapeutic insights
173
Neuromuscular disorders: orphan diseases deserve attention
174
Neuromuscular disorders: therapeutic advances
175
Neuromuscular dysfunction associated with delayed weaning from mechanical ventilation in patients with respiratory failure
176
NEUROMUSCULAR EFFECTS OF CISATRACURIUM IN MORBIDLY OBESE PATIENTS
177
Neuromuscular Electric Stimulation Versus Traditional Treatment on Harris Hip Score in Cases of Avascular Necrosis of Femoral Head After Kidney Transplantation
178
NEUROMUSCULAR ELECTRICAL STIMULATION OF MEDIUM an‎d LOW FREQUENCY ON THE QUADRICEPS FEMORIS
179
Neuromuscular Electrical Stimulation of the Cricothyroid Muscle in Patients With Suspected Superior Laryngeal Nerve Weakness
180
Neuromuscular excitability properties in myotonic dystrophy type 1
181
Neuromuscular function and bone density as independent predictors of fracture in older women: A 10-year longitudinal study
182
Neuromuscular implications in left ventricular hypertrabeculation/noncompaction
183
Neuromuscular mechanisms and anthropometric modifications in the initial stages of independent gait
184
Neuromuscular Mechanisms of Primary Peristalsis
185
Neuromuscular neutral zones response to cyclic lumbar flexion
186
Neuromuscular neutral zones response to static lumbar flexion: Muscular stability compensator
187
Neuromuscular neutral zones sensitivity to lumbar displacement rate
188
Neuromuscular objectives of the human masticatory apparatus during static biting
189
Neuromuscular Problems in the Patients With COVID-19: A Review Study
190
Neuromuscular recovery in ACL reconstruction with Bone-Tendon-Patellar-Bone and Semitendinosus-Gracilis autograft
191
Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial
192
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy
193
Neuromuscular variables affecting the magnitude of force loss after eccentric exercise
194
Neuromuscular versus behavioural influences on reaching performance in young and elderly women
195
Neuromyelitis optica — Devicʹs syndrome, update
196
Neuromyelitis Optica and Nucleotide Variations of Aquaporin-4 Gene
197
Neuromyelitis optica in a patient with an early onset demyelinating episode: Clinical and autoantibody findings
198
Neuromyelitis optica in a pregnant woman with systemic lupus erythematous: A case report
199
Neuromyelitis Optica in Children: A Rare Entity
200
Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross‑sectional study
201
Neuromyelitis optica: what it is and what it might be
202
Neuromyotonia
203
Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)
204
Neuromythology of Einstein’s brain
205
Neuron Cell Type-specific SNAP-25 Expression Driven by Multiple Regulatory Elements in the Nematode Caenorhabditis elegans
206
Neuron death due to unfolded protein response in gangliosidosis
207
Neuron death in ALS may be due to effects of neighbours
208
Neuron firing in driven nonlinear integrate-and-fire models
209
Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors
210
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis Review Article
211
Neuron Mathematical Model Representation of Neural Tensor Network for RDF Knowledge Base Completion
212
Neuron Numbers and Volume of the Amygdala in Subjects Diagnosed with Bipolar Disorder or Schizophrenia
213
Neuron source energy on resonance absorption
214
Neuronal activation and plasticity in Schistosoma mansoni infected mice
215
Neuronal activation in response to isoproterenol (Iso) in 6-day-old rat pups
216
Neuronal activity in the basal ganglia and thalamus in patients with dystonia
217
Neuronal and glial cell types revealed by NADPH-diaphorase histochemistry in the retina of a teleost fish, the grass goby (Zosterisessor ophiocephaluSy Perciformes, Gobiidae)
218
Neuronal and glial changes in the brain resulting from explosive blast in an experimental model
219
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
220
Neuronal and microglial cathepsins in aging and age-related diseases
221
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
222
Neuronal Approach and the Use of KIK-NET Network to Generate Response Spectrum on the Surface
223
Neuronal assemblies: necessity, signature and detectability
224
Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis
225
Neuronal BC1 RNA: Microtubule-dependent Dendritic Delivery
226
Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease
227
Neuronal Cell Death in the Ischemic Spinal Cord: The Effect of Methylprednisolone
228
Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on
229
Neuronal cell protective and antioxidant effects of phenolics obtained from Zanthoxylum piperitum leaf using in vitro model system
230
Neuronal Cell Reconstruction with Umbilical Cord Blood Cells in the Brain Hypoxia-Ischemia
231
Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features
232
Neuronal ceroid-lipofuscinosis: late infantile form or juvenile form?
233
Neuronal Changes in Normal Human Aging and Alzheimerʹs Disease
234
Neuronal circuitries involved in thermoregulation
235
Neuronal codes: reading them and learning how their structure influences network organization
236
Neuronal computers Original Research Article
237
Neuronal connections of the paratrigeminal nucleus: a topographic analysis of neurons projecting to bulbar, pontine and thalamic nuclei related to cardiovascular, respiratory and sensory functions
238
Neuronal contact guidance in magnetically aligned fibrin gels: effect of variation in gel mechano-structural properties
239
Neuronal Control of Metabolism through Nutrient-Dependent Modulation of Tracheal Branching
240
Neuronal correlates of “free will” are associated with regional specialization in the human intrinsic/default network
241
Neuronal Correlates of Colour-Graphemic Synaesthesia: Afmri Study
242
Neuronal correlates of context-related behavior
243
Neuronal Correlates of Obsessions in the Caudate Nucleus
244
Neuronal damage after hypothermic circulatory arrest and retrograde cerebral perfusion in the pig
245
Neuronal damage of the dorsal hippocampus induced by long-term right common carotid artery occlusion in rats
246
Neuronal death in the central nervous system during development
247
Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection
248
Neuronal differentiation modifies the effect of ethanol exposure on voltage-dependent calcium channels in NG 108-15 cells
249
Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface
250
Neuronal differentiation of mouse amnion membrane derived stem cells in response to neonatal brain medium
251
Neuronal Differentiation of Mouse Embryonic Stem Cells: Lineage Selection and Forced Differentiation Paradigms
252
Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)
253
Neuronal DNA damage correlates with overexpression of interleukin-1β converting enzyme in APPV717F mice
254
Neuronal effects of auditory distraction on visual attention
255
Neuronal Environment: the Brain Homeostasis in Health and Disease: W. Waltz, Humana Press, ISBN 0-89603-882-3, $145.00
256
Neuronal event detection in fMRI time series using iterative deconvolution techniques
257
Neuronal evolution: analysis of regulatory genes in a first-evolved nervous system, the hydra nervous system
258
Neuronal expression of Raf protooncogene in the brain stem of adult guinea pig
259
Neuronal feedback between brain and inner ear for growth of otoliths in fish Original Research Article
260
Neuronal firing activity in the dorsal hippocampus during the auditory discrimination oddball task in awake rats: relation to event-related potential generation
261
Neuronal function in chronic spinal cord injury: Divergence between locomotor and flexion- and H-reflex activity
262
Neuronal injury and death following focal mild brain injury: The role of network excitability and seizure
263
Neuronal Innervation, Intracellular Signal Transduction and Intercellular Coupling: a Model for Syncytial Tissue Responses in the Steady State
264
Neuronal Inputs from the Hypothalamus and Brain Stem to the Medial Preoptic Area of the Ram: Neurochemical Correlates and Comparison to the Ewe
265
Neuronal instability: implications for Rettʹs syndrome
266
Neuronal insulin signal transduction mechanisms in diabetes phenotypes
267
Neuronal intranuclear inclusion disease: neuropathologic study of a case
268
Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity
269
Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity
270
Neuronal lipofuscinosis
271
Neuronal loss and β-amyloid removal in the amygdala of people with Down syndromesmall star, filled
272
Neuronal loss in the colon of constipated Parkinsonʹs disease patients mimics that in the brain
273
Neuronal MAP2 mRNA: Species-dependent Differential Dendritic Targeting Competence
274
Neuronal maturation and N-acetyl-l-aspartic acid development in human fetal and child brains
275
Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable
276
Neuronal Microtubule-associated Proteins: Insights into Their Structures and Functions
277
Neuronal migrational disorders in children with epilepsy: MRI, interictal SPECT and EEG comparisons
278
Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues
279
Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds
280
Neuronal nicotinic receptors and ligands
281
Neuronal nitric oxide synthase (NNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implication for oxidative stress
282
Neuronal nitric oxide synthase activity is increased during granulomatous inflammation in the colon and caecum of pigs infected with Schistosoma japonicum
283
Neuronal Nitric Oxide Synthase Expression in the Anterior Vaginal Wall of Patients with Stress Urinary Incontinence
284
Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons
285
Neuronal Nitric Oxide Synthase is Refractory to Mechanism-Based Inactivation in GH3Pituitary Cells
286
Neuronal Nitric Oxide Synthase–Membrane Phospholipid Interactions
287
Neuronal NO synthase (NOS1) is a major candidate gene for asthma
288
Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system
289
Neuronal organization and cell interactions of the cat stellate ganglion
290
Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging
291
Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity
292
Neuronal Phenomena Associated with Vigilance and Consciousness: From Cellular Mechanisms to Electroencephalographic Patterns,
293
Neuronal plasticity and survival in mood disorders
294
Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes
295
Neuronal porosome – The secretory portal at the nerve terminal: Its structure–function, composition, and reconstitution
296
Neuronal projections from ventral tegmental area to forebrain structures in rat studied by manganese-enhanced magnetic resonance imaging
297
Neuronal representations of cognitive state: reward or attention?
298
Neuronal stem cells: a tale of promise and caution
299
Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntingtonʹs Disease Treatment Original Research Article
300
Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?
301
Neuronal subserving of behavior before and after chronic ethanol treatment
302
Neuronal substrates of sensory gating within the human brain
303
Neuronal substrates participating in attentional set-shifting of rules for visually guided motor selection: a functional magnetic resonance imaging investigation
304
Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops
305
Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia
306
Neuronal synchrony detection on single-electron neural networks
307
Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Downʹs syndrome: a gene expression study
308
Neuronal toxicity of biopolymer-template synthesized ZnO nanoparticles
309
Neuronal, mesenchymal and hematopoietic cell derived from CD34− lin− cell from adult bone marrow
310
Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome
311
Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series
312
Neuronavigation assisted endoscopic sinus surgery
313
Neuronavigation for Intraoperative Localization of Cerebral Aneurysms
314
Neuronavigation for transcranial magnetic stimulation (TMS): Where we are and where we are going
315
Neuron-based VLSI architecture for real-time camera distortion correction
316
Neuron-controlled robots
317
Neuron-MOS Parallel Search Hardware for Real-Time Signal Processing
318
Neuronorm is a potent and water soluble neurokinin A receptor antagonist
319
Neurons and neuronal systems involved in the pathophysiologies of Rett syndrome
320
Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimerʹs disease
321
Neurons don’t represent
322
Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits
323
Neurons lose inhibitions in epilepsy
324
Neurons regenerate in absence of reactive astrocytes
325
Neurons, Cooperativity and the Role of Noise in Brain
326
Neurons, glia, and plasticity in normal brain aging
327
Neurons, viscose fluids, freshwater polyp hydra-and self-organizing information systems
328
Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke
329
Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome
330
Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome
331
Neuron-Specific enolase as a marker for acute ischemic stroke: A systematic review
332
Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy
333
Neuron-specific enolase in cerebrospinal fluid as a neurochemical marker for brain damage in acute lymphoblastic leukemia
334
Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation
335
Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children
336
Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis
337
Neuron-specific susceptibility to apolipoprotein E4
338
Neuron-synapse IC chip-set for large-scale chaotic neural networks
339
Neuron-tumor Interaction in Prostate Cancer: Implications and Future Perspective
340
Neuron-type polypyrrole device prepared by electrochemical polymerization method and its properties
341
Neuro-oncology for non-oncologists
342
Neuro-oncology for Nurses; Edited by Douglas Guerrero, Whur Publishers Ltd, £24.50
343
Neuro-oncology: diagnosis in the spotlight
344
Neuro-oncology: new insights and advances in treatment
345
Neuro-oncology: oligodendroglioma and molecular markers
346
Neuro-oncology: setting new standards of management
347
Neuro-oncology: the growing role of chemotherapy in glioma
348
Neuro-Ophthalmologic and Electroretinographic Finding in Pantothenate Kinae-Aociated Neurodegeneration (formerly Hallervorden-patz yndrome)
349
Neuro-Ophthalmologic Preentation of Hemicrania Continua
350
Neuro-ophthalmologic Recovery Following Endoscopic Endonasal Resection of Pituitary Macro-adenomas with Apoplexy
351
Neuro-ophthalmology review manual, revied 5th edition: Lanning B. Kline and Frank J. Bajanda. lack Incorporated: Thorofare, NJ; 2004.288 page$44.95 UDIBN 1-55642-672-0Media type: Review Manual
352
Neuro-Ophthalmology, The Requiite in Ophthalmology. Edited by Timothy J. Martin and Jame J. Corbett. t. Loui, Miouri, Moby Inc., 2000. Index, illutrated, 256 page. $89.00.
353
Neuro-ophthalmology: Neuronal Control of Eye Movements .A. Straube and U. Büttner Editors Basel Karger (2007).
354
Neuro-ophthalmology—Diagnoi and Management. Liu GT, Volpe NJ, Baletta L. New York, W.B. aunder, 2001. 756 page, index, illutrated. About $135.00
355
Neuro-optimal operation of a variable air volume HVAC&R system
356
Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications
357
Neuro-otologic Manifestations of Multiple Sclerosis
358
Neuro-otological features of Benign Paroxysmal Vertigo and Benign Paroxysmal Positioning Vertigo in children: A follow-up study
359
Neuropathic agents and pain. New strategies
360
Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases
361
Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases
362
Neuropathic diabetic patients do not have reduced variability of plantar loading during gait
363
Neuropathic elbow arthropathy: A review of six cases
364
Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion
365
Neuropathic injury to the levator ani occurs in 1 in 4 primiparous women
366
Neuropathic manifestations in rheumatoid arthritis : A clinical and electrophysiological assessment in a small sample of Iraqi patients.
367
Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations
368
Neuropathic Osteoarthropathy in a Patient with Congenital Insensitivity to Pain
369
NEUROPATHIC PAIN
370
Neuropathic pain
371
Neuropathic pain
372
Neuropathic pain in hereditary coproporphyria
373
Neuropathic pain in soft tissue complaints
374
Neuropathic pain research pinpoints new role for microglia
375
Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail
376
Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail
377
Neuropathic Pain: A Review of Interneuronal Disinhibition
378
Neuropathic pain: aetiology, symptoms, mechanisms, and management
379
Neuropathic symptoms and findings in women with Fabry disease
380
Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature
381
Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature
382
Neuropathies of the foot
383
Neuropathogenicity of Equine Herpesvirus 9 in Cattle
384
Neuropathologic study of long term cyanide administration to goats
385
Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats
386
Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy
387
Neuropathological assessment of artemether-treated severe malaria
388
Neuropathological Changes in Brain Cortex and Hippocampus in a Rat Model of Alzheimer’s Disease
389
NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER S DISEASE
390
Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis
391
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease
392
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?
393
Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies
394
Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms
395
Neuropathological findings in the cerebro-oculo-facio-skeletal (Pena-Shokeir II) syndrome
396
Neuropathological markers of impaired cognition in the entorhinal cortex
397
Neuropathological Staging of Alzheimer-Related Lesions: The Challenge of Establishing Relations to Age
398
Neuropathological studies of brain tissue in schizophrenia
399
Neuropathologies of the self: Clinical and anatomical features
400
Neuropathology and Genetics of Dementia, Edited by Tolnay M. and Probst A., Kluwer Academic/Plenum Publ., London, 2000.
401
Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging
402
Neuropathology of bipolar disorder
403
Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment
404
Neuropathology of developmental abnormalities
405
Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts; comparison with those of early myoclonic encephalopathy and West syndrome
406
Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs
407
Neuropathology of prion diseases
408
Neuropathology of the limbic system and brainstem in West syndrome
409
Neuropathology of tuberous sclerosis
410
Neuropathology of variant Creutzfeldt-Jakob disease
411
Neuropathy complicating diffuse infiltrative lymphocytosis
412
Neuropathy in type 1 diabetic renal transplanted patients
413
Neuropathy of the suprascapular nerve and massive rotator cuff tears: a prospective electromyographic study
414
Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease
415
Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb
416
Neuro-PD Controller of Structural System to Mitigate Earthquake Vibrations
417
Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex
418
Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex
419
Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture
420
Neuropeptide enzyme hydrolysis in human saliva
421
Neuropeptide expression following ligation of the ferret lingual nerve
422
Neuropeptide expression in the ferret trigeminal ganglion following ligation of the inferior alveolar nerve
423
Neuropeptide FF attenuates RANKL-induced differentiation of RAW264.7 cells into osteoclast-like cells
424
Neuropeptide may shift rheumatoid arthritis into remission
425
Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat
426
Neuropeptide transmitters released from VAN into the NTS play an important role in regulating food intake
427
Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease
428
Neuropeptide Y (NPY) revealed biological activity in leucocytes of Salmo salar
429
Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses
430
Neuropeptide Y administered into cerebral ventricles stimulates sucrose ingestion in the near-term ovine fetus
431
Neuropeptide Y administration into the amygdala does not affect ethanol consumption
432
Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women
433
Neuropeptide Y expression, localization and cellular transducing effects in HUVEC
434
Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke
435
Neuropeptide Y immunohistochemistry and ultrastructure of developing chromaffin tissue in the cloudy dogfish, Scyliorhinus torazame (Chondrichthyes, Elasmobranchii)
436
Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli
437
Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization
438
Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats
439
Neuropeptide Y Inhibits in Vivo Specific Antibody Production in Rats
440
Neuropeptide Y modulation of sympathetic activity in myocardial infarction
441
Neuropeptide Y mRNA expression in interneurons in rat spinal cord
442
Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation
443
Neuropeptide Y receptors; antisecretory control of intestinal epithelial function
444
Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway
445
Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep
446
Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study
447
Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non–ethanol-abstinent, Wistar rats
448
Neuropeptide Y Y1 receptor functional responsiveness is enhanced during cardiomyocyte hypertrophy
449
Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation
450
Neuropeptide Y1 Receptor NPY1R: Discovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo
451
Neuropeptide Y1 receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.
452
Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat
453
NEUROPEPTIDES (SP an‎d CGRP) AUGMENT IL-1 BETA PRODUCTION IN HSV-INFECTED MACROPHAGES
454
Neuropeptides and endothelial injury in cutaneous vasculitis
455
Neuropeptides and obesity
456
Neuropeptides: opportunities for drug discovery
457
Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report
458
Neuropharmacological activity of the aqueous leaf extract of Croton zambesicus (euphorbiaceae) in some laboratory animals
459
Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease
460
Neuropharmacological Effect of the Rhizome of Drynaria quercifolia in Mice
461
Neuropharmacological Effects of Chassalia curviflora (Rubiaceae) Leaves in Swiss Albino Mice Model
462
Neuro-pharmacological effects of Crinum zeylanicum in mice
463
Neuropharmacological effects of methanolic extracts of Rubus fruticosus L.
464
Neuropharmacological effects of Nigella sativa
465
Neuropharmacological effects of Ocimum basilicum and its constituents
466
Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats
467
Neuropharmacological key to cortical plasticity found
468
Neuropharmacological properties of farnesol in Murine model
469
Neuropharmacological studies of ethanolic extract of Vaccinium corymbosum on Alzheimer’s type dementia and catatonia in Swiss albino mice
470
Neuropharmacological studies with spect in neuropsychiatric disorders
471
Neuropharmacology of depression in aging and age-related diseases
472
Neuropharmacology of endogenous, synthetic andphytocannabinoids for pain management
473
Neuropharmacology of timing and time perception
474
Neuropharmacology of timing and time perception: [Cognitive Brain Research 3 (1996) 227–242]
475
Neurophenomenology and the study of self-consciousness
476
Neurophil reactive chlorinating species target tissue plasmalogens: Production of 2-chlorohexadecal
477
Neurophysical theory of coherence and correlations of electroencephalographic and electrocorticographic signals
478
Neurophysiologic and intellectual evaluation of beta-thalassemia patients
479
Neurophysiologic assessment of mucopolysaccharidosis III
480
Neurophysiologic consequences of neonatal ethanol exposure in the rat
481
Neurophysiologic correlates of deficient phonological representations and object naming in prematurely born children
482
Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy
483
Neurophysiologic detector—a selective and sensitive tool in high-performance liquid chromatography
484
Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy
485
Neurophysiological and behavioral concomitants of mild brain injury in collegiate athletes
486
Neurophysiological and behavioral indices of time pressure effects on visuomotor task performance
487
Neurophysiological and behavioural evidence for an olfactory function for the dorsal organ and a gustatory one for the terminal organ in Drosophila melanogaster larvae
488
Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation
489
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes
490
Neurophysiological assessment of the sedative and analgesic effects of a constant rate infusion of dexmedetomidine in the dog
491
Neurophysiological assessment of trigeminal nerve reflexes in disorders of central and peripheral nervous system
492
Neurophysiological bases underlying the organization of intentional actions and the understanding of others’ intention
493
Neurophysiological changes associated with psychiatric symptoms in HIV-infected individuals without AIDS
494
Neurophysiological Changes Associated with Selective Neuronal Damage in Hippocampus following Transient Forebrain Ischemia
495
Neurophysiological characteristics of photophobia in migraine
496
Neurophysiological correlate of clinical signs in Parkinsonʹs disease
497
Neurophysiological Correlates of Affiliative Behaviour between Humans and Dogs
498
Neurophysiological correlates of subjective significance
499
Neurophysiological correlates of the recognition of facial expressions of emotion as revealed by magnetoencephalography
500
Neurophysiological effects of recurrent laryngeal and thoracic vagus nerves on mediating the neurogenic inflammation of the trachea, bronchi, and esophagus of rats
501
Neurophysiological evaluation of symptomatically unaffected muscles in post polio syndrome (PPS)
502
Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine
503
Neurophysiological evidence for categorical perception of color
504
Neurophysiological evidence of cognitive inhibition anomalies in persons with major depressive disorder
505
Neurophysiological follow-up of motor cortical output in stroke patients
506
Neurophysiological index is a marker of functional impairment in amyotrophic lateral sclerosis
507
Neurophysiological indices of attention to speech in children with specific language impairment
508
Neurophysiological indices of strategy development and skill acquisition
509
Neurophysiological investigation of a chronic sensory ataxia
510
Neurophysiological marker of inhibition distinguishes language groups on a non-linguistic executive function test
511
Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes
512
Neurophysiological markers of contextual processing: The relationship between P3b and Gamma synchrony and their modulation by arousal, performance and individual differences
513
Neurophysiological markers of early language acquisition: from syllables to sentences
514
Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 1. Recovery time of corticospinal tract direct waves elicited by pairs of transcranial electrical stimuli
515
Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 2. Relationship between epidurally and muscle recorded MEPs in man
516
Neurophysiological Methods in Occupational and Environmental Health: Methodology and Recent Findings
517
Neurophysiological monitoring in vascular surgery
518
Neurophysiological Responses to Traumatic Reminders in the Acute Aftermath of Serious Motor Vehicle Collisions Using [15O]-H2O Positron Emission Tomography
519
Neurophysiological self-control: Modulation in all things
520
Neurophysiological signals of working memory in normal aging
521
Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal
522
Neurophysiological study in Pelizaeus-Merzbacher disease
523
Neurophysiological study of corticomotor pathways in restless legs syndrome
524
Neurophysiological study of facial chorea in patients with Huntingtonʹs disease
525
Neurophysiological study of secondary synchronous occipito-frontopolar spikes in childhood
526
Neurophysiological study on possible protective and therapeutic effects of Sidr (Zizyphus spina-christi L.) leaf extract in male albino rats treated with pentylenetetrazol
527
Neurophysiological study on sensorimotor control mechanism in superior colliculus of echolocating bat
528
Neurophysiological techniques in patients who are secondarily non-responsive to Botulinum toxin
529
Neurophysiologist reprimanded by UK General Medical Council
530
Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS)
531
Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans
532
Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates
533
Neurophysiology and neuroanatomy of smooth pursuit in humans
534
Neurophysiology and neuroanatomy of smooth pursuit: Lesion studies
535
Neurophysiology for Detection of High Risk for Psychosis
536
Neurophysiology in the intensive care unit: Size (of surals) matters
537
Neurophysiology of Parkinsonʹs disease: from basic research to clinical correlates
538
Neurophysiology of Rett syndrome
539
Neurophysiology of Social Conduct and Impact of Adverse Exposures
540
Neurophysiology of spasms
541
Neurophysiology of swallowing
542
Neurophysiology of the neurogenic lower urinary tract disorders
543
Neurophysiology of Touretteʹs syndrome: pathophysiological considerations
544
Neurophysiology of unimanual motor control and mirror movements
545
Neurophysiology reference tome
546
Neuro-PID tracking control of a discharge air temperature system
547
Neuropil Alteration of the Habenula Nucleus in the Experimental Model of Schizophrenia Induced by Ketamine
548
Neuropilin-1 Expreion by Endothelial Cell and Retinal Pigment Epithelial Cell in Choroidal Neovacular Membrane
549
Neuropilins and semaphorins — from angiogenesis to autoimmunity
550
Neuroplasticity and schizophrenia
551
Neuroplasticity as a function of second language learning: Anatomical changes in the human brain
552
Neuroplasticity changes during space flight Original Research Article
553
Neuroplasticity Changes of Rat Brain by Musical Stimuli during Fetal Period
554
Neuroplasticity of face primary motor cortex control of orofacial movements
555
Neuroplasticity of face sensorimotor cortex and implications for control of orofacial movements
556
Neuroplasticity: Evidence from aphasia
557
Neuropolitics gone mad
558
Neuroprophylaxis with aminophylline and magnesium sulfate?
559
Neuroprostheses for leg function after spinal-cord injury
560
Neuroprotection after cardiac arrest
561
Neuroprotection After Traumatic Brain Injury: Is There any Hope?
562
Neuroprotection against ischemic brain injury conferred by a novel nitrate ester
563
Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the AB-injected rat
564
NEURO-PROTECTION AND NEURO-THERAPY EFFECTS OF Acalypha indica Linn. WATER EXTRACT EX VIVO ON Musculus gastrocnemius Frog
565
Neuroprotection and pharmacotherapy for motor symptoms in Parkinsonʹs disease
566
Neuroprotection and the role of neuroglobin
567
Neuroprotection by KATP channels
568
Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid
569
Neuroprotection disappointment yet aGAIN
570
Neuroprotection Effect of Quercetin on TNF- Levels and Gene Expression of Caspase 3 in MPTP-Induced Male NMRI Mice
571
Neuroprotection failure in stroke
572
Neuroprotection for acute ischaemic stroke: hope reignited
573
Neuroprotection for Parkinsonʹs disease: a call for clinically riven experimental design
574
Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?
575
Neuroprotection in Cardiac Surgery
576
Neuroprotection in epilepsy: The Holy Grail of antiepileptogenic therapy
577
Neuroprotection in Glaucoma
578
Neuroprotection in Glaucoma
579
Neuroprotection in multiple sclerosis
580
Neuroprotection in Parkinsonʹs Disease
581
Neuroprotection in Parkinsonʹs disease: and now for something completely different?
582
Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxy- phenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal injury
583
Neuroprotective (+) 3S, 4S cannabinoids with modified 5′-side chain
584
Neuroprotective activities of acai berries (Euterpe sp.): A review
585
Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium–binding proteins
586
Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases
587
Neuroprotective Agents for Management of Parkinson’s disease
588
Neuroprotective agents: Cannabinoids
589
Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice
590
Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines
591
Neuroprotective and Anti-inflammatory Role of Atorvastatin and Its Interaction with Nitric Oxide (NO) in Chronic Constriction Injury-induced Neuropathic Pain
592
Neuroprotective and anti-neuroinflammatory activity of frankincense in bile duct ligation-induced hepatic encephalopathy
593
Neuroprotective and memory enhancing effects of Zataria multiflora in lipopolysaccharide-treated rats
594
Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior
595
Neuroprotective and Nootropic Activity of Carica Papaya Seeds on Diabetes induced Cognitive Decline in Rats
596
Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity
597
Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury
598
Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells
599
Neuroprotective Consequences of Postconditioning on Embolic Model of Cerebral Ischemia in Rat
600
Neuroprotective Effect of Matricaria chamomilla Extract on Motor Dysfunction Induced by Transient Global Cerebral Ischemia and Reperfusion in Rat
601
Neuroprotective Effect of 4T1 and Sertoli Cells CoTransplantation in Animal Model of Brain Ischemia
602
Neuroprotective effect of Acorus calamus Linn. extract on a rat model of chronic constriction injury of median nerve-induced peripheral neuropathy
603
Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and ultrastructural studies
604
Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation
605
Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model
606
Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia
607
Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion
608
Neuroprotective Effect of Celastrus Paniculatus Seed Extract on Epilepsy and Epilepsy-associated Cognitive Deficits
609
Neuroprotective Effect of Coenzyme Q10 in Chronic Constriction Injury-Induced Neuropathic Pain in Rat
610
Neuroprotective effect of Coenzyme Q10 in hippocampal injury in Balb/c mouse
611
Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein
612
Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia
613
Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress
614
Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2
615
Neuroprotective Effect of Erythropoietin in Postoperation Cervical Spinal Cord Injury: Case Report and Review
616
Neuroprotective effect of ethanolic leaf extract of Commiphora caudata (Wight Arn) against lipopolysaccharide-induced neurotoxicity in Wistar rats
617
Neuroprotective Effect of Exogenous Melatonin on Dopaminergic Neurons of the Substantia Nigra in Ovariectomized Rats
618
Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: Relevance to neuropathy
619
Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats
620
Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia
621
Neuroprotective effect of Launaea taraxacifolia against neuroinflammation, memory loss and neurobehavioral deficit in a rat model of hypertension: biochemical and immunohistochemical approaches
622
Neuroprotective effect of L-deprenyl on the expression level of the Mst1 gene and inhibition of apoptosis in rat-model spinal cord injury
623
Neuroprotective effect of melatonin in a rat model ofstreptozotocin-induced diabetic neuropathy: Light andelectron microscopic study
624
Neuroprotective Effect of Melatonin in the Hippocampus of Rat’s Brain in Normal Aging Model
625
Neuroprotective Effect of Melatonin on Brain Damage Induced by Acute Global Cerebral Ischemia in Cats
626
Neuroprotective effect of memantine on serum S100-B levels after on-pump coronary artery bypass graft surgery: A randomized clinical trial
627
Neuroprotective effect of methanolic extract of Sargassum wightii on rotenone-induced parkinsonism-like symptoms in Wistar albino rats
628
Neuroprotective Effect of Paroxetine on Memory Deficit Induced by Cerebral Ischemia after Transient Bilateral Occlusion of Common Carotid Arteries in Rat
629
Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia
630
Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus
631
Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimerʹs Disease
632
Neuroprotective Effect of Quercetin in a Model of Parkinson’s Disease in Rat: A histochemical Analysis
633
Neuroprotective effect of selective antegrade cerebral perfusion during prolonged deep hypothermic circulatory arrest: Cerebral metabolism evidence in a pig model
634
Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats
635
Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model
636
Neuroprotective Effect of Total and Sequential Extract of Scrophularia striata Boiss. in Rat Cerebellar Granule Neurons Following Glutamate- Induced Neurotoxicity: An In-vitro Study
637
NEUROPROTECTIVE EFFECT OF VITAMIN C AGAINST PTZ INDUCED APOPTOTIC NEURODEGENERATION IN ADULT RAT BRAIN
638
Neuroprotective effect of water lily (Nymphaea pubescens Willd) seed ethanolic extract against trimethyltin-induced cognitive impairment and neurodegeneration in mice
639
Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study
640
Neuroprotective Effects of 1,8-Cineole on Apoptosis Inhibition and Bcl-2/Caspase-3 mRNA Expression in the Hippocampus of Epileptic Pilocarpine Model Rats
641
Neuroprotective Effects of Acetyl-l-Carnitine After Stroke in Rats, , ,
642
Neuroprotective effects of alpha-lipoic acid on radiation-induced brainstem injury in rats
643
Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats
644
Neuroprotective Effects of Berberine Hydrochloride on Methamphetamine-induced Cognitive Dysfunction: Immunohistochemical and Behavioral Studies in Rats
645
Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat
646
Neuroprotective effects of caffeine against beta-amyliod neurotoxicity: The involvement of glycogen synthase kinase-3β protein
647
Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s disease in Rats
648
Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review
649
Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats
650
Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats
651
Neuroprotective effects of cobalt ferrite nanoparticles coated with sumac on damaged sciatic nerve recovery
652
Neuroprotective effects of cognitive enrichment
653
Neuroprotective Effects of Combined Treatment with Minocycline and Olfactory Ensheathing Cells Transplantation against Inflammation and Oxidative Stress after Spinal Cord Injury
654
Neuroprotective effects of Coriandrum sativum and its constituent, linalool: A review
655
Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat
656
Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro
657
Neuroprotective Effects of Curcumin Against Transient Global Ischemia are Dose and Area Dependent
658
Neuroprotective Effects of Curcumin on the Proliferation and Viability of Neural Stem Cells against H2O2
659
Neuroprotective effects of cystamine in aged parkinsonian mice
660
Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinsonʹs Disease
661
Neuroprotective Effects of Epigallocatechin-3-Gallate in an Experimental Model of Alzheimer’s Disease in Rat: A Histological Study
662
Neuroprotective effects of Equisetum telmateia in rat
663
Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment
664
Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
665
Neuroprotective Effects of Exercise on Brain Edema and Neurological Movement Disorders Following the Cerebral Ischemia and Reperfusion in Rats
666
Neuroprotective Effects of Fe3O4 Nanoparticles Coated with Omega-3 as a Novel Drug for Recovery of Sciatic Nerve Injury in Rats
667
Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells
668
Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies
669
Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer’s Disease
670
Neuroprotective effects of intense training and thyme honey on hippocampal cognitive pathways in diabetic rats
671
Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study
672
Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrosative stress, and mitochondrial damage in SH-SY5Y neuroblastoma cells
673
Neuroprotective Effects of Medicinal Plants and Their Constituents on Different Induced Neurotoxicity Methods: A Review
674
Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study
675
Neuroprotective effects of naturally occurring biflavonoids
676
Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells
677
Neuroprotective Effects of Normobaric Hyperoxia and Transplantation of Encapsulated Choroid Plexus Epithelial Cells on The Focal Brain Ischemia
678
Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats
679
Neuroprotective effects of Pinus eldarica in a mouse model of pentylenetetrazole-induced seizures
680
Neuroprotective Effects of Pramipexole in Parkinson s Disease Induced by Rotenone in Mice
681
Neuroprotective Effects of Progesterone on Damage Elicited by Acute Global Cerebral Ischemia in Neurons of the Caudate Nucleus
682
Neuroprotective effects of propolis and caffeic acid phenethyl ester (CAPE) on the radiation-injured brain tissue (Neuroprotective effects of propolis and CAPE)
683
Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol
684
Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats
685
Neuroprotective effects of Salvia aristata Aucher ex Benth. on hydrogen peroxide induced apoptosis in SH-SY5Y neuroblastoma cells
686
Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats
687
Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain
688
Neuroprotective Effects of Semaglutide in Endotoxemia Mouse Model
689
Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress
690
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering
691
Neuroprotective effects of Tacca chantrieri Andre against lipopolysaccharide-induced cognitive impairment and neuroinflammation
692
Neuroprotective effects of Tiliacora triandra leaf extract in a mice model of cerebral ischemia reperfusion
693
Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE
694
Neuroprotective Effects of Vitamin D on Patients With Traumatic Brain Injury: A Clinical Trial
695
Neuroprotective Effects of Vitexin and Cajanus cajan Extract Against Pb-induced Neurotoxicity in Wistar Rats
696
Neuroprotective effects of voluntary wheel running and eriobotrya japonica flower extract on Parkinsonian rats
697
Neuroprotective effects of walnut (Juglans regia L.) in nervous system disorders: A comprehensive review
698
Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease
699
Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats
700
Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment
701
Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia
702
Neuroprotective effects of α-lipoic acid and its positively charged amide analogue
703
Neuroprotective gene profile in the brain of magnesium-deficient mice
704
Neuroprotective mechanism of bromocriptine
705
Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds
706
Neuroprotective Plants; What, How, an‎d Why? A Narrative Review
707
Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses
708
Neuroprotective Potential of Trans-Anethole Following Crush Injury of the Sciatic Nerve in Rats
709
Neuroprotective Properties of Melissa Officinalis L. Extract Against Ecstasy-Induced Neurotoxicity
710
Neuroprotective properties of Melissa officinalisafter hypoxic-ischemic injury both in vitro and in vivo
711
Neuroprotective Properties of Photobiomodulation in Retinal Regeneration in Rats: Perspectives From Interaction Levels
712
Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes
713
Neuroprotective role of curcumin on the hippocampus against the structural and serological alterations of streptozotocin-induced diabetes in Sprague Dawely rats
714
Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats
715
Neuroprotective roles of flavonoid “hispidulin” in the central nervous system: A review
716
Neuroprotective Strategies in the Perioperative Period: A Systematic Review
717
Neuroprotective therapy for acute ischaemic stroke: down, but not out
718
Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat
719
Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review
720
Neuroproteomics comes of age
721
Neuropsychiaric perspective and recommendations
722
Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis
723
Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review
724
Neuropsychiatric aspects in Munchausenʹs syndrome
725
Neuropsychiatric aspects of epilepsy in children
726
Neuropsychiatric aspects of patients with hypothalamic hamartomas
727
Neuropsychiatric changes after liver transplantation
728
Neuropsychiatric Complications Following Liver Transplantation
729
NEUROPSYCHIATRIC COMPLICATIONS IN LIVER TRANSPLANT PATIENTS IN A TERTIARY HOSPITAL IN SINGAPORE
730
Neuropsychiatric Complications of COVID-19: What is to be Expected
731
Neuropsychiatric effects of medications for allergic diseases
732
Neuropsychiatric features of systemic lupus erythematosus
733
Neuropsychiatric Function and Dehydroepiandrosterone Sulfate in Elderly Women: A Prospective Study
734
Neuropsychiatric Illness: A Case for Impaired Neuroplasticity and Possible Quantum Processing Derailment in Microtubules
735
Neuropsychiatric implications of basal ganglia dysfunction
736
Neuropsychiatric Lupus
737
Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests,
738
Neuropsychiatric Manifestations in a Patientwith Panhypopituitarism
739
Neuropsychiatric Manifestations of COVID-19 in Hospitalized Pediatrics: A Multicenter Cross-sectional Study
740
Neuropsychiatric Manifestations of Partial Agenesis ofthe Corpus Callosum: A Case Report and Literature Review
741
Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature
742
Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate
743
Neuropsychiatric reaction induced by abacavir
744
Neuropsychiatric reactions with mefloquine chemoprophylaxis
745
Neuropsychiatric sequelae in a case of St. Louis Encephalitis
746
Neuropsychiatric Symptoms As The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case With Klinefelterʹʹs Syndrome
747
Neuropsychiatric Syndromes and Occupational Exposure to Zinc Phosphide in Egypt
748
Neuropsychiatric systemic lupus erythematosus: Correlation of brain MR imaging, CT, and SPECT
749
Neuropsychiatric toxicity of Ifosfamide in patients admitted for chemotherapy
750
Neuropsychiatry and Behavioral Neuroscience
751
Neuropsychiatry in old age : by C. Stefanis and H. Hippius, 1996, Hogrefe & Huber Publishers, Seattle, USA, 171 pages, US$ 32, ISBN 0-88937-137-7
752
Neuropsychiatry, second edition.R.B. Schiffer, S.M. Roa and B.S. Fogel, Editors, Lippincott Williams & Wilkins, Philadelphia (2003) $169, 1312 pages.
753
Neuropsychiatry—a discipline for the future
754
Neuropsychiatryʹs offspring
755
Neuropsychiatry—The mind embrained?
756
Neuro-Psychoanalysis May Enliven the Mindbrain Sciences
757
Neuropsychologic and Functional Recovery From Severe Carbon Monoxide Poisoning Without Hyperbaric Oxygen Therapy, , ,
758
Neuropsychologic Changes After Coronary Artery Bypass Grafting: Use of Reliable Change Indices
759
Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading
760
Neuropsychologic Impairment in Patients with Nonepileptic Seizures
761
Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery
762
Neuropsychologic Theory and Findings in Attention-Deficit/Hyperactivity Disorder: The State of the Field and Salient Challenges for the Coming Decade
763
Neuropsychological abnormalities in cirrhosis include learning impairment
764
Neuropsychological and anatomical correlates of E4 in Alzheimerʹs disease
765
Neuropsychological and behavioral disorders as presentation symptoms in two brothers with early-infantile Niemann-Pick type C
766
Neuropsychological and cognitive psychophysiological substrates of impulsive aggression
767
Neuropsychological and Diagnostic Differences Between Recidivistically Violent Not Criminally Responsible and Mentally Ill Prisoners
768
Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine, alendronate, and testosterone
769
Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome
770
Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial
771
Neuropsychological and neurological correlates in an elderly rural population
772
Neuropsychological and neurophysiological deficits in extremely high velocity traumatic brain injury: A case report
773
Neuropsychological and Neuropsychiatric Deficits Following Traumatic Brain Injury: Common Patterns and Neuropathological Mechanisms
774
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinsonʹs disease: a randomised, multicentre study
775
Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study
776
Neuropsychological and QEEG assessment of adult ADHD
777
Neuropsychological aspects of chronic relapsing pancreatitis: A longitudinal case study
778
Neuropsychological aspects of epilepsy surgery
779
Neuropsychological aspects of Tourette syndrome: A review
780
Neuropsychological aspects of type of epilepsy and etiological factors in adults
781
Neuropsychological assessment and volumetric magnetic resonance imaging of the corpus callosum in dementia
782
Neuropsychological Assessment In Epilepsy Surgery – Preliminary Experience In A Rural Tertiary Care Hospital In North East Malaysia
783
Neuropsychological assessment in patients evaluated for hyperthermia for metastatic nonsmall lung carcinoma (FDA phase 1 and phase 2)
784
Neuropsychological assessment of a rare systemic vascular disorder: a case study of Rendu—Osler—Weber syndrome
785
Neuropsychological Assessment of Organic Solvent Effects in South Africa: Test Selection, Adaptation, Scoring, and Validation Issues
786
Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness
787
Neuropsychological assessment of relatively intact individuals: Psychometric lessons from an HIV+ sample
788
Neuropsychological assessment of the blind and visually impaired
789
Neuropsychological assessments before and aftertreatment in patients with anorexia nervosa and bulimianervosa
790
Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases
791
Neuropsychological changes and treatment compliance in older adults with sleep apnea
792
Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS)
793
Neuropsychological characterization of hepatic encephalopathy
794
Neuropsychological complaint base rates in personal injury, revisited
795
Neuropsychological consequences of bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinsonʹs disease: A 1-year longitudinal follow-up
796
Neuropsychological consequences of HIV in children: A review of current literature
797
Neuropsychological consequences of right thalamic haemorrhage: Case study and review
798
Neuropsychological consequences of sequential concussions in a female college basketball player
799
Neuropsychological correlates between working memory and executive functioning
800
Neuropsychological correlates of adjunct therapy with a nutritional/vitamin supplement in a medical patient sample
801
Neuropsychological Correlates of Community Function among Major Depressive Disorder Outpatients without Comorbidity in Hong Kong: An Exploratory Cross‑Sectional Study
802
Neuropsychological correlates of dominance, warmth, and extraversion in neurodegenerative disease
803
Neuropsychological correlates of Gulf War syndrome
804
Neuropsychological correlates of homocysteine levels in euthymic bipolar patients
805
Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression
806
Neuropsychological correlates of opioid dependence and withdrawal
807
Neuropsychological correlates of psychopathic traits in a non-incarcerated sample
808
Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis
809
Neuropsychological correlates of self-reported impulsive aggression in a college sample
810
Neuropsychological correlates of violence and aggression: A review of the clinical literature
811
Neuropsychological decline following herpes zoster without encephalitis: A case study
812
Neuropsychological Decomposing Stroop Interference Into Different Cognitive Monitoring: An Exploratory Factor Analysis
813
Neuropsychological deficit profiles in senile dementia of the Alzheimerʹs type
814
Neuropsychological deficits among patients with late-onset minor and major depression
815
Neuropsychological deficits associated with chronic hepatitis C among male veterans
816
Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment
817
Neuropsychological deficits in marijuana smokers
818
Neuropsychological deficits in probands from multiply-affected schizophrenic families
819
Neuropsychological deficits of patients with chronic or acute cerebellar lesions
820
Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment
821
Neuropsychological Disorders in Patients with Brain Tumor
822
Neuropsychological dissociations between motion and form perception suggest functional organization in extrastriate cortical regions in the human brain
823
Neuropsychological double dissociation between linguistic levels: Clinical linguistic evidence from Iranian aphasic patients
824
Neuropsychological dysfunction after minimally invasive direct coronary artery bypass grafting
825
Neuropsychological Dysfunction in Children with Borderline Personality Disorder Features: A Preliminary Investigation
826
Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease
827
Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation
828
Neuropsychological dysfunction in patients with end-stage pulmonary disease: Lung transplant evaluation
829
Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis
830
Neuropsychological Effects of Chronic Exposure to Environmental Dioxins and Furans
831
Neuropsychological effects of epilepsy and antiepileptic drugs
832
Neuropsychological effects of exposure to sheep dip
833
Neuropsychological effects of long-term exposure to organophosphates in sheep dip
834
Neuropsychological effects of seizures
835
Neuropsychological effects of stress on social phobia with and without comorbid depression
836
Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills
837
Neuropsychological evaluation in the diagnosis and management of sports-related concussion
838
Neuropsychological Evaluation of Older Children : By Ralph M. Reitan and Deborah Wolfson, South Tucson, AZ: Neuropsychology Press, 1992. + 814 pp
839
Neuropsychological evidence for dimensional schizotypy: Implications for creativity and psychopathology
840
Neuropsychological exploration of alleged mold neurotoxicity
841
Neuropsychological explorations of memory and cognition: Essay in honor of Nelson butters :Eidted by Laird S. Cermak, N ew York: Plenum Press, 1994.
842
Neuropsychological features of diffuse Lewy body disease
843
Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation
844
Neuropsychological findings in adult attention deficit disorder
845
Neuropsychological findings in young-adult stroke patients
846
Neuropsychological follow-up of high risk infants at school age: Wechsler Verbal-Performance discrepancies
847
Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimers disease
848
Neuropsychological function and psychosocial status of alcohol rehabilitation program residents
849
Neuropsychological function in adults with attention-deficit hyperactivity disorder
850
Neuropsychological function in female victims of intimate partner violence with and without posttraumatic stress disorder
851
Neuropsychological function in unmedicated recurrent brief depression
852
Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson’s disease
853
Neuropsychological functioning in a subclinical obsessive-compulsive sample
854
Neuropsychological Functioning in Adolescent Children of Mothers with a History of Bipolar or Major Depressive Disorders
855
Neuropsychological functioning in adult insulin-dependent diabetes mellitus (IDDM) patients
856
Neuropsychological Functioning in Bipolar Disorder and Schizophrenia
857
Neuropsychological functioning in chronic lyme disease: The role of mental effort
858
Neuropsychological Functioning in Danish Gulf War Veterans
859
Neuropsychological functioning in depressed adolescent girls
860
Neuropsychological functioning in kleptomania
861
Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants
862
Neuropsychological Functioning in Migraine Headache, Nonheadache Chronic Pain, and Mild Traumatic Brain Injury Patients
863
Neuropsychological Functioning in Obsessive-Compulsive Washers: Drug-Naive Without Depressive Symptoms
864
Neuropsychological functioning in people with ADHD across the lifespan
865
Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers
866
Neuropsychological functioning in trichotillomania
867
Neuropsychological functioning in two brothers with X-linked adrenoleukodystrophy: A longitudinal case study of phenotypic variation and bone marrow transplant outcome
868
Neuropsychological Functioning in Youth with Bipolar Disorder
869
Neuropsychological functioning of children and adolescents with conduct disorder and aggressive-assaultive features
870
Neuropsychological functioning of dementia patients with psychosis
871
Neuropsychological Functioning of Inmates Referred for Psychiatric Treatment
872
Neuropsychological Functioning: Comparison of Mothers at High- and Low-Risk for Child Physical Abuse
873
Neuropsychological functions and the BASC
874
Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction
875
Neuropsychological impairment after hemorrhagic stroke in basal ganglia
876
Neuropsychological impairment associated with compulsive hoarding
877
Neuropsychological impairment in fibromyalgia: Relation to depression, fatigue, and pain
878
Neuropsychological information in the Wechsler adult intelligence scale—revised
879
Neuropsychological Interventions: Clinical Practice and Research: By Paul J. Eslinger. New York: The Guilford Press, 2002, 359 pages
880
Neuropsychological Manifestation in Ebola: A Concern
881
Neuropsychological measures probably facilitate heritability research of ADHD
882
Neuropsychological outcome and quantitative neuroimaging in mild head injury,
883
Neuropsychological Outcome and the Extent of Resection in the Unilateral Temporal Lobectomy
884
Neuropsychological outcome following focal cortical removal for intractable epilepsy in children
885
Neuropsychological Outcome following Resuscitation after Out-of-Hospital Cardiac Arrest: A One-Year Follow-Up
886
Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery
887
Neuropsychological Outcome of Head Injury Using a Short Battery
888
NEUROPSYCHOLOGICAL OUTCOMES OF NOCTURNAL ASTHMA
889
Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes
890
Neuropsychological parameters of pediatric migraineurs and tensioneurs
891
Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder
892
Neuropsychological performance in a sample of 13–25 year olds with a history of non-psychotic major depressive disorder
893
Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data
894
Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: A longitudinal, naturalistic study
895
Neuropsychological Performance in Children and Adolescents with Obsessive-Compulsive Disorder and Influence of Clinical Variables
896
Neuropsychological Performance in First-Episode Adolescents with Schizophrenia: A Comparison with First-Episode Adults and Adolescent Control Subjects
897
Neuropsychological performance in gravesʹ hyperthyroidism: Evidence for executive dysfunction
898
Neuropsychological Performance in Gulf War Era Veterans: Motivational Factors and Effort
899
Neuropsychological Performance in Gulf War Era Veterans: Neuropsychological Symptom Reporting
900
Neuropsychological Performance in Gulf War Era Veterans: Traumatic Stress Symptomatology and Exposure to Chemical–Biological Warfare Agents
901
Neuropsychological performance in men and women at risk for hypertension
902
Neuropsychological performance in normal pregnancy and preeclampsia
903
Neuropsychological performance in pediatric bipolar disorder
904
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity
905
Neuropsychological performance of a clinical sample of extremely obese individuals
906
Neuropsychological Performance of Adults Evidencing Attention-Deficit Hyperactivity Disorder
907
Neuropsychological performance of monozygotic twins discordant for bipolar disorder
908
Neuropsychological Performance Over Time in People at High Risk of Developing Schizophrenia and Controls
909
Neuropsychological performance predicts clinical recovery in bipolar patients
910
Neuropsychological predictors of adaptive living and work behaviors
911
Neuropsychological predictors of emotional prosody: Implications for hemispheric asymmetry
912
Neuropsychological Profile at Three Months Post Injury in Patients with Traumatic Brain Injury
913
Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment
914
Neuropsychological Profile of a Large Kindred with Familial Alzheimerʹs Disease Caused by the E280A Single Presenilin-1 Mutation
915
Neuropsychological profile of patients with juvenile myoclonic epilepsy: A controlled study of 50 patients
916
Neuropsychological profile of prodromal Alzheimerʹs disease (Prd-AD) and their radiological correlates
917
Neuropsychological Profiles Associated with Subcortical White Matter Alterations and Parkinsonʹs Disease:: Implications for the Diagnosis of Dementia
918
Neuropsychological profiles of children diagnosed as specific language impaired with and without hyperlexia
919
Neuropsychological recovery from childhood moyamoya disease
920
Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis: Lung Transplant Evaluation
921
Neuropsychological sequelae in subacute home chlordane poisoning: Ten case studies
922
Neuropsychological Similarities and Differences Among Huntington’s Disease, Multiple Sclerosis, and Cortical Dementia
923
Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder
924
Neuropsychological study of ciguatera fish poisoning: A longitudinal case-control study
925
Neuropsychological Test Development and Normative Data on Hispanics
926
Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia
927
Neuropsychological test performance in a cognitively intact sample of older Japanese American adults
928
Neuropsychological Test Performance in Illiterate Subjects
929
Neuropsychological test performance of children with ADHD relative to test norms and parent behavioral ratings
930
Neuropsychological Test Performances of Young Depressed Outpatient Women: An Examination of Executive Functions
931
Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities
932
Neuropsychological testing of adults: further considerations for neurologists
933
Neuropsychological testing of high school athletes: Preliminary norms and test–retest indices
934
Neuropsychological tests and SPECT in dementing disorders
935
Neuropsychological tests predict independent activities of daily living in patients with dementia
936
Neuropsychological toxicology: Identification and assessment of human neurotoxic syndromes : Second Edition, by David E. Hartman. New York: Plenum Press, 1995. 429 pp, $59.50 hardcover
937
Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia
938
Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia
939
Neuropsychologistsʹ Practice Patterns in Assessing Premorbid Intelligence
940
Neuropsychologists’ abilities to determine the predictive value of diagnostic tests
941
Neuropsychology and linguistic aphasiology: Evidence in favor of case studies
942
Neuropsychology is nothing without control: A potential fallacy hidden in clinical studies
943
Neuropsychology of Alzheimerʹs Disease
944
Neuropsychology of bipolar disorder: a review
945
Neuropsychology of BPI and BPII
946
Neuropsychology of BPI and BPII
947
Neuropsychology of BPI and BPII
948
Neuropsychology of developmental stuttering
949
Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders
950
Neuropsychology of obsessive-compulsive disorder: a review and treatment implications
951
Neuropsychology of timing and time perception
952
Neuropsychology, the Patientʹs Experience, and the Political Forces Within Our Field
953
Neuroptera in agricultural ecosystems
954
Neuropteran (Insecta) palaeodiversity with predictions for the Cretaceous fauna of the Wealden
955
Neuroradiologic MR applications with multiparametric color composite display
956
Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome
957
Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients
958
Neuroradiology of spine degenerative diseases
959
Neuroreceptor subunit genes and the genetic susceptibility to gilles de la tourette syndrome
960
Neurorehabilitation, the Practical Method of Returning to Work after Stroke
961
Neurorehabilitation: no more constraint for large randomised trials
962
Neuroretinal function is normal in early dementia of the Alzheimer type
963
Neurosarcoidosis
964
Neurosarcoidosis presenting as a large suprasellar mass: Magnetic resonance imaging findings
965
Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature
966
Neurosarcoidosis: a clinical dilemma
967
Neurosarcoidosis: a treatable cause of vestibular dysfunction
968
Neurosarcoidosis: Findings in MRI
969
Neuroscience and computing algorithms
970
Neuroscience and the soul: Competing explanations for the human experience
971
Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury
972
Neuroscience as an Insightful Decision Support Tool for Sustainable Development
973
Neuroscience meets dance/movement therapy: Mirror neurons, the therapeutic process and empathy
974
Neuroscience output of China: A MEDLINE-based bibliometric study
975
Neuroscience research on the addictions: A prospectus for future ethical and policy analysis
976
Neuroscience, neuroimaging and the law
977
Neuroscience, quantum indeterminism and the Cartesian soul
978
Neuroscience: Where is it heading?: Some reflections on the future of brain research at the end of the second millenium
979
Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders
980
Neurosciences Quiz: Subclinical rhythmic electrographic discharges of adults (SREDA): Case Presentation
981
Neurosciences, psychiatrie et psychopathologie : quelles évolutions pour la relation clinique ?
982
Neuroscientific challenges to free will and responsibility
983
Neuroscientists discover disgusting regions of the brain
984
Neuroscientists hear impassioned plea from Superman
985
Neuroscientists take a BOLD step forward
986
Neuro-Second Order Sliding Mode Control of a DFIG Supplied by a Two-Level NSVM Inverter for Wind Turbine System
987
Neurosensory changes of palatal mucousa following Le Fort I osteotomy
988
Neuro-short-term load forecast of the power system in Kuwait
989
Neuro-simulation analysis of pressure maintenance operations in gas condensate reservoirs
990
Neuro-simulation modeling of chemical flooding
991
Neurosolver: Neuromorphic general problem solver
992
Neurosphere-Free Transdifferentiation of Rat Bone Marrow Stromal Stem Cells Into Retinal Cells and Retinal Pigment Epithelium
993
Neurospora crassa CyPBP37: A Cytosolic Stress Protein that is able to Replace Yeast Thi4p Function in the Synthesis of Vitamin B1
994
Neurospora crassa FKBP22 Is a Novel ER Chaperone and Functionally Cooperates with BiP
995
Neurosteroid analogues. Part 13: Synthetic methods for the preparation of 2β-hydroxygonane derivatives as structural mimics of ent-3α-hydroxysteroid modulators of GABAA receptors
996
Neurosteroid analogues: synthesis of 6-aza-allopregnanolone
997
Neurosteroid analysis by gas chromatography–atmospheric pressure photoionization–tandem mass spectrometry Original Research Article
998
Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease
999
Neurosteroids in Rat Brain: Extraction, Isolation, and Analysis by Nanoscale Liquid Chromatography-Electrospray Mass Spectrometry
1000
Neurosteroids: 7-aza-allopregnanolone—a poor substitute for allopregnanolone